A Saudi man gets a dose of a coronavirus disease (COVID-19) vaccine, in Riyadh
A Saudi man gets a dose of a coronavirus disease (COVID-19) vaccine, in Riyadh, Saudi Arabia Dec. 17, 2020.

RIYADH - Saudi Arabia began inoculating people in the kingdom with a COVID-19 vaccine on Thursday, becoming the first Arab country to roll out the Pfizer-BioNTech jab.

Saudi Arabia received two shipments of the vaccine Wednesday.

Earlier this week, health authorities asked citizens and residents to register to receive the vaccine, which they said would be given free to all in the country.

The kingdom has reported around 360,000 cases coronavirus case with 6,080 deaths since the start of the pandemic. Although it began lifting restrictions several months ago, the country so far has avoided a new wave of infections.
 

Nurse Carolyn Grausgruber gives volunteer Ithaca firefighter Wade Bardo, of Erin, N.Y., an injection as the world's biggest…
US Panel Expected to Endorse Second COVID-19 Vaccine
Outside expert advisers expected to recommend vaccine developed by Moderna

Health Minister Tawfiq al-Rabiah was one of the first people to receive the vaccine, rolling up his sleeve to receive the inoculation in front of the media.

"Today marks the start of relief to this crisis," Rabiah told reporters at a vaccination center with more than 550 inoculation stations in Riyadh.

"For the past nine months, I anxiously monitored the number of registered cases," he said. "But today, I will happily monitor the numbers of those getting vaccinated."

Vaccination stations will be set up throughout the kingdom, he said.

Saudi Arabia earlier this week asked citizens and residents to sign up for its vaccination program. The first phase will include people most exposed to the disease. The second and third stages will target those over the age of 50 before the vaccine is made available to the wider public.

Citizens and foreign residents lined up to receive the vaccine Thursday morning, as part of the phase 1 roll-out which includes those most exposed and vulnerable to the disease.

Special Section